Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,509,392
  • Shares Outstanding, K 422,128
  • Annual Sales, $ 9,467 M
  • Annual Income, $ 2,673 M
  • EBIT $ 3,488 M
  • EBITDA $ 3,975 M
  • 60-Month Beta 0.96
  • Price/Sales 5.60
  • Price/Cash Flow 16.74
  • Price/Book 16.76

Options Overview Details

View History
  • Implied Volatility 25.87% (-3.50%)
  • Historical Volatility 22.82%
  • IV Percentile 22%
  • IV Rank 16.79%
  • IV High 46.55% on 04/07/25
  • IV Low 21.70% on 02/20/25
  • Expected Move (DTE 1) 2.30 (1.78%)
  • Put/Call Vol Ratio 0.31
  • Today's Volume 1,841
  • Volume Avg (30-Day) 3,153
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 77,886
  • Open Int (30-Day) 64,857
  • Expected Range 126.84 to 131.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 1.61
  • Number of Estimates 10
  • High Estimate 1.69
  • Low Estimate 1.53
  • Prior Year 1.48
  • Growth Rate Est. (year over year) +8.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
118.94 +8.57%
on 02/12/26
132.49 -2.54%
on 02/12/26
+4.48 (+3.59%)
since 01/16/26
3-Month
115.25 +12.04%
on 11/19/25
132.49 -2.54%
on 02/12/26
+10.99 (+9.30%)
since 11/18/25
52-Week
115.25 +12.04%
on 11/19/25
177.00 -27.05%
on 03/10/25
-27.35 (-17.48%)
since 02/18/25

Most Recent Stories

More News
The Top 5 Analyst Questions From Zoetis’s Q4 Earnings Call

The Top 5 Analyst Questions From Zoetis’s Q4 Earnings Call

ZTS : 129.13 (+2.84%)
2 S&P 500 Stocks to Research Further and 1 We Question

2 S&P 500 Stocks to Research Further and 1 We Question

WM : 234.06 (-0.49%)
GM : 83.67 (+3.02%)
ZTS : 129.13 (+2.84%)
3 S&P 500 Stocks Worth Investigating

3 S&P 500 Stocks Worth Investigating

TT : 459.44 (-2.33%)
BSX : 76.28 (-0.01%)
ZTS : 129.13 (+2.84%)
ZTS Q4 Deep Dive: Product Innovation and Competitive Pressures Shape Outlook

ZTS Q4 Deep Dive: Product Innovation and Competitive Pressures Shape Outlook

ZTS : 129.13 (+2.84%)
Zoetis’s (NYSE:ZTS) Q4 CY2025 Sales Top Estimates

Zoetis’s (NYSE:ZTS) Q4 CY2025 Sales Top Estimates

ZTS : 129.13 (+2.84%)
Zoetis: Q4 Earnings Snapshot

Zoetis: Q4 Earnings Snapshot

ZTS : 129.13 (+2.84%)
Zoetis Reports Fourth Quarter and Full Year 2025 Results

Reports Revenue of $2.4 Billion, Growing 3%, and Net Income of $603 Million, or $1.37 per Diluted Share, Increasing 4% and 6%, Respectively, on a Reported Basis for Fourth Quarter 2025 ...

ZTS : 129.13 (+2.84%)
Zoetis (ZTS) Reports Q4: Everything You Need To Know Ahead Of Earnings

Zoetis (ZTS) Reports Q4: Everything You Need To Know Ahead Of Earnings

ZTS : 129.13 (+2.84%)
Zoetis Declares Second Quarter 2026 Dividend

The Board of Directors of Zoetis Inc . (NYSE:ZTS) has declared a dividend of $0.53 per share for the second quarter of 2026. The dividend will be paid on Tuesday, June 2, 2026, to all holders...

ZTS : 129.13 (+2.84%)
Do Wall Street Analysts Like Zoetis Stock?

Zoetis stock has underperformed the broader market over the past year, while analysts remain cautiously bullish about its prospects.

XLV : 157.67 (+0.19%)
$SPX : 6,881.31 (+0.56%)
ZTS : 129.13 (+2.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified...

See More

Key Turning Points

3rd Resistance Point 135.41
2nd Resistance Point 132.30
1st Resistance Point 130.72
Last Price 129.13
1st Support Level 126.02
2nd Support Level 122.91
3rd Support Level 121.33

See More

52-Week High 177.00
Fibonacci 61.8% 153.41
Fibonacci 50% 146.13
Fibonacci 38.2% 138.84
Last Price 129.13
52-Week Low 115.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar